Form D Beyond Capital Ventures
http://archive.fast-edgar.com/20260901/ABZ2222MZ222C2Z2222222Z9A4TVL92S3282
Filed on: September 1, 2026
Form 6-K NIO Inc. For: Sep 01
http://archive.fast-edgar.com/20260901/A8B2O22D8222M2ZA222K2CZZQNDB72R2Z282
Filed on: September 1, 2026
Form 4 WESTLAKE CORP For: Aug 31 Filed by: Darby Tommy
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 6-K Electra Battery Material For: Sep 01
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-41356
Electra Battery Materials Corporation(Translation of registrant's name into English)
133 Richmond St W, Suite 602Toronto, Ontario, M5H 2L3 Canada(416) 900-3891 (Address of principal executive office)
Indicate by check mark... (continue reading...)
Form 6-K ASTRAZENECA PLC For: Sep 01
FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Issuer
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For the
month of September 2026
Commission
File Number: 001-11960
AstraZeneca PLC
1
Francis Crick Avenue
Cambridge
Biomedical Campus
Cambridge
CB2 0AA
United
Kingdom
Indicate
by check mark whether the registrant files or will file annual
reports under cover of... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Invivyd, Inc. For: Aug 30
-
Form 6-K RedHill Biopharma Ltd. For: Sep 01
-
Form 424B2 UBS AG
-
Form 6-K COCA-COLA EUROPACIFIC For: Sep 01
-
Form 8-K Upstream Bio, Inc. For: Sep 01
-
Form 6-K ASTRAZENECA PLC For: Sep 01
-
Form 6-K TURKCELL ILETISIM HIZMET For: Sep 01
-
Form 6-K VersaBank For: Sep 01
-
Form 8-K Adicet Bio, Inc. For: Sep 01
-
Form 6-K Bitzero Holdings Inc. For: Sep 01
-
Form 8-K BioXcel Therapeutics, For: Aug 31
-
Form 8-K NovoCure Ltd For: Sep 01
-
Form 8-K AEye, Inc. For: Sep 01
-
Form 6-K Satellos Bioscience Inc. For: Sep 01
-
Form 497K BLACKROCK NATURAL RESOUR
-
Form 6-K Collective Mining Ltd. For: Sep 01
-
Form 424B2 HSBC USA INC /MD/
-
Form 8-K MiniMed Group, Inc. For: Sep 01
-
Form 8-K Medtronic plc For: Sep 01
-
Form 8-K Target Hospitality Corp. For: Sep 01
-
Form 8-K Nova Minerals Corp For: Sep 01
-
Form D AmTru AI Inference Ventu
-
Form 13F-HR AGUR PROVIDENT & TRAININ For: Jun 30
-
Form 144 ZKH Group Ltd Filed by: Han Yunjie
-
Form 144 NetEase, Inc. Filed by: Mo Bin
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form PREM14A Distribution Solutions For: Sep 01
-
Form 6-K Millennium Group Interna For: Sep 01
-
Form 8-K Enovis CORP For: Aug 31
-
Form 6-K WEBUY GLOBAL LTD For: Sep 01
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 4 Baozun Inc. For: Aug 28 Filed by: Yu Bin Helen
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 4 Anteris Technologies For: Aug 28 Filed by: L1 Capital Pty Ltd
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 8-K Highlands REIT, Inc. For: Sep 01
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 6-K NOVARTIS AG For: Sep 01
-
Form 3 Qfin Holdings, Inc. For: Aug 25 Filed by: Lou Dong
-
Form 4 Baozun Inc. For: Aug 28 Filed by: Qiu Wenbin
-
Form 144 Youdao, Inc. Filed by: Wu Yinghui
-
Form D/A IITM Unicorn Frontier
-
Form 4 NOVA LTD. For: Sep 01 Filed by: Wolfing Shay
-
Form 424B2 CITIGROUP INC
-
Form 424B3 Nexera Technologies Ltd
-
Form 1-U Wellstreet Senior Living For: Sep 01
-
Form 144 Youdao, Inc. Filed by: Peng Su
